Steven D. Rubin
CIK: 0001381874
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Aug 7, 2026[ENTX]
Entera Bio Ltd.
Award(A)Direct19.1K shares- - Jul 24, 2026OPK
OPKO HEALTH, INC.
Tax Payment(F)Direct53.3K shares at avg. $1.22$65K - Jun 24, 2026NAGE
Niagen Bioscience, Inc.
Award(A)DirectStock Option (right to buy)
31.7K shares- - Jun 8, 2026ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
4K shares- - Jun 4, 2026RDVT
Red Violet, Inc.
Award(A)Direct2.2K shares- - Feb 12, 2026[ENTX]
Entera Bio Ltd.
Purchase(P)Direct5K shares at avg. $1.49$7K - Feb 9, 2026[ENTX]
Entera Bio Ltd.
Purchase(P)Direct10K shares at avg. $1.20$12K - Jan 24, 2026ELOX
Eloxx Pharmaceuticals, Inc.
Exercise(M)Direct1.9K shares- - Jan 9, 2026COCP
Cocrystal Pharma, Inc.
Award(A)DirectStock Options (Right to Buy)
16.4K shares- - Dec 19, 2025RDVT
Red Violet, Inc.
Award(A)Direct4.5K shares- - Sep 19, 2025ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
179.9K shares- - Jun 24, 2025NAGE
Niagen Bioscience, Inc.
Award(A)DirectStock Option (right to buy)
20K shares- - May 27, 2025OPK
OPKO HEALTH, INC.
Award(A)DirectStock Option (Right to Buy)
437.5K shares- - Mar 19, 2025RDVT
Red Violet, Inc.
Sale(S)Direct10K shares at avg. $38.93$389K - Jan 24, 2025ELOX
Eloxx Pharmaceuticals, Inc.
Exercise(M)Direct3.8K shares- - Nov 4, 2024RDVT
Red Violet, Inc.
Award(A)Direct8K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)Direct12K shares- - Oct 9, 2024COCP
Cocrystal Pharma, Inc.
Award(A)Direct19K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 |  [ENTX] Entera Bio Ltd. | Award(A) | 19,117 | - | $0 | Direct |
| Jul 24, 2026 |  OPK OPKO HEALTH, INC. | Tax Payment(F) | 53,266 | $1.22 | $64,985 | Direct |
| Jun 24, 2026 |  NAGE Niagen Bioscience, Inc. | Award(A) Stock Option (right to buy) | 31,746 | - | - | Direct |
| Jun 8, 2026 |  ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 4,018 | - | - | Direct |
| Jun 4, 2026 |  RDVT Red Violet, Inc. | Award(A) | 2,179 | - | $0 | Direct |
| Feb 12, 2026 | [ENTX] Entera Bio Ltd. | Purchase(P) | 5,000 | $1.49 | $7,450 | Direct |
| Feb 9, 2026 | [ENTX] Entera Bio Ltd. | Purchase(P) | 10,000 | $1.20 | $12,000 | Direct |
| Jan 24, 2026 | ELOX Eloxx Pharmaceuticals, Inc. | Exercise(M) | 1,875 | - | $0 | Direct |
| Jan 9, 2026 |  COCP Cocrystal Pharma, Inc. | Award(A) Stock Options (Right to Buy) | 16,410 | - | - | Direct |
| Dec 19, 2025 | RDVT Red Violet, Inc. | Award(A) | 4,450 | - | - | Direct |
| Sep 19, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 179,854 | - | - | Direct |
| Jun 24, 2025 | NAGE Niagen Bioscience, Inc. | Award(A) Stock Option (right to buy) | 20,000 | - | - | Direct |
| May 27, 2025 | OPK OPKO HEALTH, INC. | Award(A) Stock Option (Right to Buy) | 437,500 | - | - | Direct |
| Mar 19, 2025 | RDVT Red Violet, Inc. | Sale(S) | 10,000 | $38.93 | $389,300 | Direct |
| Jan 24, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Nov 4, 2024 | RDVT Red Violet, Inc. | Award(A) | 8,000 | - | $0 | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Award(A) | 12,000 | - | $0 | Direct |
| Oct 9, 2024 | COCP Cocrystal Pharma, Inc. | Award(A) | 18,957 | - | $0 | Direct |
1-18 of 18 transactions
About Rubin Steven D
Rubin Steven D (SEC CIK 0001381874) files insider reports with the SEC as Director of Entera Bio Ltd. ([ENTX]), Executive VP-Administration of OPKO HEALTH, INC. (OPK) and Director of Niagen Bioscience, Inc. (NAGE). Signal8 also holds filings tied to 3 other companies.
Signal8 holds 18 ownership filings by Rubin Steven D (1 Form 3, 17 Form 4), filed between Oct 11, 2024 and Aug 7, 2026. Those filings report 18 transactions, from Oct 9, 2024 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rubin Steven D's filings is in JERUSALEM.
Recent filings by Rubin Steven D
- Aug 7, 2026: Grant or award of [ENTX] shares (Form 4, code A).
- Jul 24, 2026: Tax withholding of OPK shares (Form 4, code F).
- Jun 24, 2026: Grant or award of NAGE derivative securities (Form 4, code A).
- Jun 8, 2026: Grant or award of ELOX derivative securities (Form 4, code A).
- Jun 4, 2026: Grant or award of RDVT shares (Form 4, code A).